Abstract
Interpenetrating polymer network (IPN) based drug delivery system is basically designed to deliver drugs at a predetermined rate for a desired period of time with minimum fluctuation. Due to its physical and biological characteristics such as enhanced solubility of hydrophobic drugs, excellent swelling capacity, imparting drug stability in the formulations, biodegradability, biocompatibility, weak antigenecity and targeting of drug in a specific tissue make it suitable for drug delivery as well as biomedical applications. IPN based drug delivery is primarily used for controlled release of drugs. These systems are also used for tissue engineering such as cartilage scaffolds, bone substitutes etc. The purpose of this review article is to cover recent advances on IPN based on its utilization as drug delivery matrix system for pharmaceutical applications as well as in tissue engineering for biomedical applications. Consequently, IPN is regarded as one of the most valuable novel biomaterials.
Keywords: Interpenetrating polymer network, controlled release, biomaterial, drug delivery, tissue engineering, cartilage scaffolds, IPN BASED TABLETS, glycosaminoglycan, spectroscopy
Current Drug Therapy
Title: Pharmaceutical and Biomedical Applications of Interpenetrating Polymer Network
Volume: 6 Issue: 4
Author(s): Neelam Jain, Pramod Kumar Sharma, Arunabha Banik, Amit Gupta and Vineet Bhardwaj
Affiliation:
Keywords: Interpenetrating polymer network, controlled release, biomaterial, drug delivery, tissue engineering, cartilage scaffolds, IPN BASED TABLETS, glycosaminoglycan, spectroscopy
Abstract: Interpenetrating polymer network (IPN) based drug delivery system is basically designed to deliver drugs at a predetermined rate for a desired period of time with minimum fluctuation. Due to its physical and biological characteristics such as enhanced solubility of hydrophobic drugs, excellent swelling capacity, imparting drug stability in the formulations, biodegradability, biocompatibility, weak antigenecity and targeting of drug in a specific tissue make it suitable for drug delivery as well as biomedical applications. IPN based drug delivery is primarily used for controlled release of drugs. These systems are also used for tissue engineering such as cartilage scaffolds, bone substitutes etc. The purpose of this review article is to cover recent advances on IPN based on its utilization as drug delivery matrix system for pharmaceutical applications as well as in tissue engineering for biomedical applications. Consequently, IPN is regarded as one of the most valuable novel biomaterials.
Export Options
About this article
Cite this article as:
Jain Neelam, Kumar Sharma Pramod, Banik Arunabha, Gupta Amit and Bhardwaj Vineet, Pharmaceutical and Biomedical Applications of Interpenetrating Polymer Network, Current Drug Therapy 2011; 6 (4) . https://dx.doi.org/10.2174/157488511798109547
DOI https://dx.doi.org/10.2174/157488511798109547 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
Call for Papers in Thematic Issues
Novel Therapeutic Approaches and Biomarkers for Chronic Kidney Disease (CKD)
The thematic issue on "Novel Therapeutic Approaches and Biomarkers for CKD" aims to provide a comprehensive exploration of cutting-edge strategies for the management of chronic kidney disease (CKD). This issue will delve into emerging therapeutic targets, focusing on critical aspects such as podocyte injury, endothelial dysfunction, and tubulointerstitial fibrosis, which ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Substance P in Rheumatic Diseases
Current Rheumatology Reviews Oral Tolerance and TGF-β -Producing Cells
Inflammation & Allergy - Drug Targets (Discontinued) Sulfonamide Agents for Treatment of Staphylococcus MRSA and MSSA Infections of the Central Nervous System
Central Nervous System Agents in Medicinal Chemistry Cerebrospinal Fluid, Brain Electrolytes Balance, and the Unsuspected Intrinsic Property of Melanin to Dissociate the Water Molecule
CNS & Neurological Disorders - Drug Targets Role of Old Antibiotics in Multidrug Resistant Bacterial Infections
Current Drug Targets Animal Models Used for the Evaluation of Antiretroviral Therapies
Current HIV Research Acanthamoeba-Bacteria: A Model to Study Host Interaction with Human Pathogens
Current Drug Targets Role of Pituitary Adenylate Cyclase-Activating Polypeptide in Nociception and Migraine
CNS & Neurological Disorders - Drug Targets microRNAs-based Predictor Factor in Patients with Migraine-ischemic Stroke
MicroRNA Characterization and antiherpetic activity of native and chemically sulfated polysaccharide from <i>Adenanthera pavonina</i>
Current Pharmaceutical Biotechnology Increased Risk of Falls, Fall-related Injuries and Fractures in People with Type 1 and Type 2 Diabetes - A Nationwide Cohort Study
Current Drug Safety Chitinases: Biomarkers for Human Diseases
Protein & Peptide Letters Recent Trends in Antifungal Agents: A Reference to Formulation, Characterization and Applications
Drug Delivery Letters Microscopies at the Nanoscale for Nano-Scale Drug Delivery Systems
Current Drug Targets Pharmacodynamics and Pharmacokinetics of Antifungals for Treatment of Invasive Aspergillosis
Current Pharmaceutical Design Pregnancy Associated Brucellosis
Recent Patents on Anti-Infective Drug Discovery Update on Diagnostic and Treatment of Uncomplicated and Complicated Malaria in Adults and Selected Vulnerable Populations
Infectious Disorders - Drug Targets Invasive Aspergillosis: Focus on New Approaches and New Therapeutic Agents
Current Medicinal Chemistry - Anti-Infective Agents Editorial: [Hot Topic: Central Nervous System Drugs in the Treatment of Neurological Disorders]
Central Nervous System Agents in Medicinal Chemistry Treatment of Chronic Migraine with Intramuscular Pericranial Injections of Onabotulinumtoxin A
Recent Patents on CNS Drug Discovery (Discontinued)